• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nemera’s Innovation Center reaches 100 employees

January 10, 2019 By drugdelivery

Nemera Innovation Center - 100 employees(Press Release) – Nemera‘s celebrated an important milestone: its Innovation center has just hired its 100th employee.

The Innovation Center, a multi-discipline drug delivery device development expertise center, was created in 2008. Early on, it included a few engineers, who worked on product development. Over the last 10 years, it has grown consistently to reach 100 employees and more than 250 square meters of laboratory space.

“Considering that our Innovation Center started with just 12 people, 10 years ago, hiring our 100th team member is a great achievement for us,” says Innovation Director, Dimitri Grasswill. “We’ve grown a loyal client base and expanded our services, in order to answer to our customers’ needs for device development. The patients’ voice is the key driver of Nemera’s product development. This growth is a result of taking care of customers, with a strong patient-focused commitment, a high level of creativity and passion every day in what we do.”

The Innovation Center is composed of a passionate team which has the objective to address your development needs.

It has different teams which strives [sic] to develop the best devices for patients’ health:

  • Patient centricity & Usability
  • Mechanical, electronical and material engineering
  • Scientific computation
  • Industrial property
  • Program management
  • Performance testing
  • Regulatory affairs
  • Design for Manufacturing

Patient centricity
As Nemera always puts patients first, technical expertise, creative design and patient’s usability assessment are central to product development. The Innovation Center carries real world evaluations, through impartial volunteers and collects user feedbacks.

Sophisticated technologies, like fast camera tracking, give engineers an inside view of the way the device is used, making it safe and accurate for the patient.

Proprietary devices and contract development
The same quality-oriented process is applied to the development of proprietary devices, to customized solutions under contract with laboratories. The development quality team guarantees full compliance not only of the final device but of all the development chain. A strong program management ensures that the project is delivered on time and in full.

You can learn more about the Innovation Center at https://www.nemera.net/innovation-development/

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Nemera

IN CASE YOU MISSED IT

  • Medtrum introduces 300-unit tubeless insulin pump
  • Baxter reports positive smart infusion pump, EMR integration data
  • Dexcom to cease G6 CGM production next year, transition fully to G7
  • Modular Medical prices $4.7M public offering
  • Medtronic studies highlight MiniMed 780G’s cost-effectiveness

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS